0001140361-23-032450.txt : 20230630 0001140361-23-032450.hdr.sgml : 20230630 20230630161220 ACCESSION NUMBER: 0001140361-23-032450 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dechant Robert Thomas CENTRAL INDEX KEY: 0001298255 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38442 FILM NUMBER: 231061837 MAIL ADDRESS: STREET 1: 350 CAMPUS DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IBEX Ltd CENTRAL INDEX KEY: 0001720420 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1717 PENNSYLVANIA AVENUE NW STREET 2: SUITE 825 CITY: WASHINGTON STATE: DC ZIP: 20006 BUSINESS PHONE: (202)289-9898 MAIL ADDRESS: STREET 1: 1717 PENNSYLVANIA AVENUE NW STREET 2: SUITE 825 CITY: WASHINGTON STATE: DC ZIP: 20006 FORMER COMPANY: FORMER CONFORMED NAME: IBEX Holdings Ltd DATE OF NAME CHANGE: 20171023 3 1 form3.xml X0206 3 2022-12-31 0 0001720420 IBEX Ltd IBEX 0001298255 Dechant Robert Thomas C/O IBEX LIMITED 1717 PENNSYLVANIA AVE. NW SUITE 825 WASHINGTON DC 20006 true true Chief Executive Officer Common Shares 206486 D Stock Option (Right to Buy Common Shares) 12.75 2030-06-30 Common Shares 50000 D Stock Option (Right to Buy Common Shares) 19 2030-08-07 Common Shares 45027 D Stock Option (Right to Buy Common Shares) 19.85 2030-12-14 Common Shares 20000 D Includes (i) 932 restricted stock units ("RSUs") that vest on July 1, 2023 and (ii) 968 RSUs that vest on August 1, 2023, all subject to continued employment. The shares subject to this option are fully vested and exercisable. Performance stock units ("PSUs") granted on December 14, 2020. Each PSU represents a contingent right to receive one share of the Company's common shares. The PSUs vest upon the Company's common shares achieving a specified price per share over a 30 day period. The Company determined that as of December 31, 2022, the Company no longer qualified as a foreign private issuer. Beginning July 1, 2023, the Reporting Person is subject to Section 16 of the Securities Exchange Act of 1934. Exhibit 24 - Power of Attorney /s/ Lisa Lenstrohm, Attorney-in-Fact 2023-06-30 EX-24 2 brhc20055322_ex24.htm EXHIBIT 24
Exhibit 24

POWER OF ATTORNEY

Know by all these presents that the undersigned hereby constitutes and appoints each of Lisa Lenstrohm, Amy VanDerSchouw and Jaime Schlomberg, and any of their substitutes, signing singly, as the undersigned’s true and lawful attorney-in-fact to:

1.
execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of IBEX Limited (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;

2.
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Forms 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission and any stock exchange or similar authority; and

3.
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that each such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned also ratifies hereby any action previously taken by each such attorney in fact that would have been authorized by this Power of Attorney if it had been in effect at the time such action was taken. The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 28th day of June 2023.
 
 
/s/ Robert Dechant
  
   
 
Name: Robert Dechant